Description
Cell Line Information:
Cell Line Name: NIH:OVCAR-3 (ATCC® HTB-161™) or OVCAR.3 or OVCAR-3
Organism: Homo sapiens, human
Tissue: ovary
Cell Type: epithelial
Culture Properties: adherent
Biosafety Level: 1
Disease; adenocarcinoma
Gender; Female
Ethnicity: Caucasian
Markers: androgen receptor, positive; estrogen receptor, positive; progesterone receptor, positive
Tumorigenic: Yes
Applications: This cell line is a suitable transfection host. It is an appropriate model system in which to study drug resistance in ovarian cancer. The presence of hormone receptors should be useful for the evaluation of hormonal therapy. Xenograft models have been used to show that treatment with 17 beta estradiol can induce progesterone receptors in this human ovarian carcinoma.
Comments: The NIH:NIH:OVCAR-3 line was established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with progressive adenocarcinoma of the ovary. Forms colonies in soft agar and has an abnormal karyotype. Resistant to clinically relevant concentrations of adriamycin, melphalan and cisplatin. Both cultured cells and xenografts exhibit androgen and estrogen receptors. NIH:OVCAR-3 is one of the cell lines of the NCI-60 panel which represents different cancer types and has been widely utilized for drug screening and molecular target identification.
The Transfection Reagent:
NIH:OVCAR-3 Cell Avalanche® Transfection Reagent is a new class of unique chemical formulations specifically formulated and optimized for transfecting NIH:OVCAR-3 cells. The proprietary formulation of lipids and polymers ensures the highest possible transfection efficiencies and viabilities for NIH:OVCAR-3 cells. For details of the developing process of this reagent, please go to: How did EZ Biosystems develop Avalanche® Cell type/cell line specific transfection reagent series?
Features:
- Unique formulation-maximize transfection performance in NIH:OVCAR-3 cells
- Extremely gentle to cells
- Deliver single or multiple plasmids
- Free of animal-derived components
- Simplest and straightforward protocols to Increase experimental throughput
- Compatible with serum
- Suitable for Reverse Transfection
- Compatible with transfection in any plate format
- Economical: High efficiency means less amount of nucleic acid & reagent is needed
- Developed and manufactured by EZ Biosystems
Transfection Performance
- Transfection efficiency up to 90%
- Viability up to 95%
Data: | ||||||
| ||||||
For Other Cells: | ||||||
NIH:OVCAR-3 Cell Avalanche® Transfection Reagent (human ovary carcinoma cell) can also be used on the following cells with high transfection efficiencies. IGROV-1 Cell |
If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200